Why the study?
Does increased soluble thrombomodulin concentration predict bleeding complications in patients receiving long-term warfarin treatment?
Does increased soluble thrombomodulin concentration predict bleeding complications in patients receiving long-term warfarin treatment?
Increased levels of soluble thrombomodulin are associated with bleeding complications during warfarin treatment, suggesting its potential as a specific marker to identify high-risk patients.
No takes yet. Share an insight, caveat, or question.
Elevated sTM was associated with bleeding on long-term warfarin; leaves open its value as a risk marker pending prospective validation.
Lind et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: